Recent Finacing
Recent Raise
Anji Pharma is a clinical-stage developer of gut-targeted metformin ANJ900 (Phase 3) and ANJ908 (Phase 2), using hub-and-spoke models and dynamic equity JVs, expanding into oncology, neuroscience, infectious disease.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Anji Pharmaceuticals.
